Trypsinogen and chymotrypsinogen: potent anti-tumour agents

,,, &

Received 03 Nov 2020, Accepted 23 Apr 2021, Accepted author version posted online: 24 Apr 2021 


Trypsinogen and chymotrypsinogen have been used clinically in tissue repair due to their ability to resolve inflammatory symptoms. Recently, novel evidence has supported the anti-tumourigenic potential of a mixture of trypsinogen and chymotrypsinogen.

Social media & sharing icons powered by UltimatelySocial